Deep Medicine Acquisition Stock Fundamentals
| DMAQDelisted Stock | USD 11.59 0.12 1.02% |
Deep Medicine Acquisition fundamentals help investors to digest information that contributes to Deep Medicine's financial success or failures. It also enables traders to predict the movement of Deep Stock. The fundamental analysis module provides a way to measure Deep Medicine's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Deep Medicine stock.
Deep |
Deep Medicine Acquisition Company Shares Owned By Insiders Analysis
Deep Medicine's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Deep Medicine Shares Owned By Insiders | 74.08 % |
Most of Deep Medicine's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Deep Medicine Acquisition is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
CompetitionBased on the latest financial disclosure, 74% of Deep Medicine Acquisition are shares owned by insiders. This is much higher than that of the Capital Markets sector and significantly higher than that of the Financials industry. The shares owned by insiders for all United States stocks is notably lower than that of the firm.
Deep Medicine Acquisition Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Deep Medicine's current stock value. Our valuation model uses many indicators to compare Deep Medicine value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Deep Medicine competition to find correlations between indicators driving Deep Medicine's intrinsic value. More Info.Deep Medicine Acquisition is rated # 4 in return on asset category among its peers. It is rated below average in current valuation category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Deep Medicine by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Deep Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Deep Medicine's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Deep Medicine could also be used in its relative valuation, which is a method of valuing Deep Medicine by comparing valuation metrics of similar companies.Deep Medicine is currently under evaluation in shares owned by insiders category among its peers.
Deep Fundamentals
| Return On Asset | -0.0176 | |||
| Current Valuation | 15.74 M | |||
| Shares Outstanding | 4.36 M | |||
| Shares Owned By Insiders | 74.08 % | |||
| Shares Owned By Institutions | 28.73 % | |||
| Number Of Shares Shorted | 10.3 K | |||
| Price To Book | 22.01 X | |||
| EBITDA | (3.99 M) | |||
| Net Income | (400.23 K) | |||
| Cash And Equivalents | 707.98 K | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 1.86 M | |||
| Current Ratio | 229.55 X | |||
| Book Value Per Share | (1.69) X | |||
| Cash Flow From Operations | (1.04 M) | |||
| Short Ratio | 0.33 X | |||
| Earnings Per Share | (0.13) X | |||
| Beta | 0.017 | |||
| Market Capitalization | 12.9 M | |||
| Total Asset | 9.78 M | |||
| Retained Earnings | (6.44 M) | |||
| Working Capital | 6.98 M | |||
| Z Score | 2.74 | |||
| Net Asset | 9.78 M |
About Deep Medicine Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Deep Medicine Acquisition's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Deep Medicine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Deep Medicine Acquisition based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Deep Medicine Acquisition Corp. does not have significant operations. The company was incorporated in 2020 and is based in New York, New York. Deep Medicine is traded on NASDAQ Exchange in the United States.
Pair Trading with Deep Medicine
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Deep Medicine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Deep Medicine will appreciate offsetting losses from the drop in the long position's value.Moving against Deep Stock
| 0.89 | KO | Coca Cola Aggressive Push | PairCorr |
| 0.86 | QLGN | Qualigen Therapeutics Trending | PairCorr |
| 0.76 | SGD | Safe and Green | PairCorr |
| 0.76 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
| 0.56 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
The ability to find closely correlated positions to Deep Medicine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Deep Medicine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Deep Medicine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Deep Medicine Acquisition to buy it.
The correlation of Deep Medicine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Deep Medicine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Deep Medicine Acquisition moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Deep Medicine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in Deep Stock
If you are still planning to invest in Deep Medicine Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Deep Medicine's history and understand the potential risks before investing.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |